A business in context

PHGE research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-01 · 0001213900-26-096273 · Items 8.01,9.01

  2. 8-K/A · Current report

    Report date 2026-08-28 · 0001213900-26-096272 · Items 8.01,9.01

  3. 8-K · Current report

    Report date 2026-08-28 · 0001213900-26-095146 · Items 8.01,9.01

  4. 8-K · Current report

    Report date 2026-08-25 · 0001213900-26-093565 · Items 5.07,9.01

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001213900-26-091780

  6. 8-K · Current report

    Report date 2026-08-05 · 0001213900-26-087839 · Items 1.01,3.02,9.01

  7. DEF 14A · Proxy statement

    Report date 2026-08-25 · 0001213900-26-087834

  8. 8-K · Current report

    Report date 2026-07-27 · 0001213900-26-082025 · Items 1.01,3.02,9.01

  9. 8-K · Current report

    Report date 2026-07-10 · 0001213900-26-077250 · Items 8.01,9.01

  10. 8-K · Current report

    Report date 2026-07-01 · 0001213900-26-075072 · Items 4.01,9.01

  11. 8-K · Current report

    Report date 2026-06-26 · 0001213900-26-072673 · Items 5.07,9.01

  12. 8-K · Current report

    Report date 2026-06-18 · 0001213900-26-069911 · Items 7.01,9.01

  13. 8-K · Current report

    Report date 2026-06-10 · 0001213900-26-068026 · Items 3.01,7.01,9.01

  14. 8-K/A · Current report

    Report date 2026-04-10 · 0001213900-26-068018 · Items 9.01

  15. DEF 14A · Proxy statement

    Report date 2026-06-26 · 0001213900-26-066341

  16. 8-K · Current report

    Report date 2026-06-02 · 0001213900-26-065850 · Items 3.02,9.01

  17. 8-K · Current report

    Report date 2026-05-27 · 0001213900-26-061772 · Items 5.02,9.01

  18. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-059587

  19. 8-K · Current report

    Report date 2026-05-05 · 0001213900-26-052213 · Items 8.01

  20. 10-K/A · Annual report

    Report date 2025-12-31 · 0001213900-26-050373

  21. 8-K · Current report

    Report date 2026-04-15 · 0001213900-26-044722 · Items 7.01,8.01,9.01

  22. 8-K · Current report

    Report date 2026-04-13 · 0001213900-26-042811 · Items 1.01,2.01,3.02,7.01,9.01

  23. 8-K · Current report

    Report date 2026-04-10 · 0001213900-26-042595 · Items 5.07

  24. 8-K · Current report

    Report date 2026-04-10 · 0001213900-26-042200 · Items 1.01,2.01,3.02,7.01,9.01

  25. 8-K · Current report

    Report date 2026-03-31 · 0001213900-26-038095 · Items 1.01,9.01

  26. 8-K · Current report

    Report date 2026-03-25 · 0001213900-26-035605 · Items 3.01,8.01,9.01

  27. DEF 14A · Proxy statement

    Report date 2026-04-10 · 0001213900-26-034099

  28. 8-K · Current report

    Report date 2026-03-13 · 0001213900-26-031587 · Items 1.01,7.01,9.01

  29. 4 · Ownership change

    Report date 2026-03-16 · 0001213900-26-031016

  30. 4 · Ownership change

    Report date 2026-03-11 · 0001213900-26-027698

  31. 8-K · Current report

    Report date 2026-03-11 · 0001213900-26-026174 · Items 5.07

  32. 8-K · Current report

    Report date 2026-03-04 · 0001213900-26-024344 · Items 5.02

  33. 8-K · Current report

    Report date 2026-02-24 · 0001213900-26-022301 · Items 5.02,8.01

  34. 8-K · Current report

    Report date 2026-02-19 · 0001213900-26-020374 · Items 5.02

  35. 4 · Ownership change

    Report date 2025-04-21 · 0001193805-25-000549

  36. 4/A · Ownership change

    Report date 2025-04-14 · 0001213900-25-033490

  37. 4/A · Ownership change

    Report date 2025-04-14 · 0001213900-25-033487

  38. 4/A · Ownership change

    Report date 2025-04-14 · 0001213900-25-033485

  39. 4/A · Ownership change

    Report date 2025-04-14 · 0001213900-25-033483

  40. 4/A · Ownership change

    Report date 2025-04-14 · 0001213900-25-033480

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001739174BiomX Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • Chardan Healthcare Acquisition Corp. · former SEC name · 2018-05-04 to 2019-10-23

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗